| Splenectomy for people with thalassaemia major or intermedia A Sharma, ME Mathew, L Puri Cochrane Database of Systematic Reviews, 2019 | 38 | 2019 |
| State of the art management of acute vaso-occlusive pain in sickle cell disease L Puri, KA Nottage, JS Hankins, DL Anghelescu Pediatric Drugs 20, 29-42, 2018 | 34 | 2018 |
| Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell disease L Puri, KJ Morgan, DL Anghelescu Current opinion in supportive and palliative care 13 (4), 402-407, 2019 | 25 | 2019 |
| Use of caplacizumab in a child with refractory thrombotic thrombocytopenic purpura. SV Bhoopalan, J Hankins, J George, A Ryder, AM Onder, L Puri Pediatric Blood & Cancer 66 (7), e27737-e27737, 2019 | 20 | 2019 |
| A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease E Rampersaud, G Kang, LE Palmer, SR Rashkin, S Wang, W Bi, ... Blood Advances 5 (14), 2839-2851, 2021 | 16 | 2021 |
| Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway P Zhao, AE Aguilar, JY Lee, LA Paul, JH Suh, L Puri, M Zhang, ... Investigational new drugs 36, 743-754, 2018 | 15 | 2018 |
| Hematopoietic stem cell transplantation for people with β‐thalassaemia A Sharma, VA Jagannath, L Puri Cochrane Database of Systematic Reviews, 2021 | 12 | 2021 |
| Prevalence of neuropathic pain in adolescents with sickle cell disease: a single‐center experience M Cregan, L Puri, G Kang, D Anghelescu Pediatric blood & cancer 69 (4), e29583, 2022 | 5 | 2022 |
| GSTM1 and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload L Puri, JM Flanagan, G Kang, J Ding, W Bi, BM McCarville, RB Loeffler, ... Journal of Clinical Medicine 8 (11), 1878, 2019 | 5 | 2019 |
| Gabapentin for acute pain in sickle cell disease: a randomized double‐blinded placebo‐controlled phase II clinical trial L Puri, K Nottage, JS Hankins, WC Wang, O McGregor, JM Gossett, ... EJHaem 2 (3), 327-334, 2021 | 3 | 2021 |
| Gabapentin for pain in sickle cell disease: Results of a randomized phase II clinical trial L Puri, D Anghelescu, J Hankins, K Nottage, W Wang, G Kang, J Gossett PEDIATRIC BLOOD & CANCER 66, 2019 | 2 | 2019 |
| COVID‐19 infection and pain in adolescents with sickle cell disease: A case series HM Heyman, NM Alberts, M Rees, L Puri, MJ Frett, DL Anghelescu EJHaem 3 (4), 1310-1315, 2022 | 1 | 2022 |
| AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis B Oskouian, JY Lee, S Asgharzadeh, R Khan, M Zhang, JR Weisbrod, ... Oncogene 43 (16), 1203-1213, 2024 | | 2024 |
| Vitamin D Levels: Associations with Acute Pain Events and Self-Reported Pain in Children with Sickle Cell Disease L Puri, NM Alberts, G Kang, J Ding, JS Hankins, AM Brandow, ... Blood 138, 3089, 2021 | | 2021 |
| PREVALENCE OF NEUROPATHIC PAIN IN ADOLESCENTS WITH SICKLE CELL DISEASE; A SINGLE CENTER EXPERIENCE L Puri, D Anghelescu, M Cregan, J Hankins PEDIATRIC BLOOD & CANCER 67, S34-S35, 2020 | | 2020 |
| Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway P Zhao, AE Aguilar, JY Lee, LA Paul, JH Suh, L Puri, M Zhang, ... Investigational New Drugs 37 (6), 1309-1309, 2019 | | 2019 |
| KETAMINE & LIDOCAINE DECREASE OPIOID CONSUMPTION DURING VASO-OCCLUSIVE CRISIS IN SICKLE CELL DISEASE L Puri, K Morgan, D Anghelescu PEDIATRIC BLOOD & CANCER 66, 2019 | | 2019 |
| TWO CASES OF NEWLY DIAGNOSED MUSCULAR DYSTROPHY DISCOVERED IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA J Miller, L Puri, AM Shayeb, V Howard PEDIATRIC BLOOD & CANCER 65, 2018 | | 2018 |
| Genetic Modifiers of Iron Overload in Sickle Cell Disease L Puri, J Hankins, C Hillenbrand, J Flanagan, G Kang, W Bi, ... PEDIATRIC BLOOD & CANCER 64, S24-S25, 2017 | | 2017 |
| IDIOPATHIC HYPEREOSINOPHILIC SYNDROME WITH CARDIAC THROMBUS IN A FOUR YEAR OLD GIRL, A CASE REPORT AND REVIEW OF THE LITERATURE L Puri, A Matsunaga PEDIATRIC BLOOD & CANCER 62, 67-68, 2015 | | 2015 |
